Key result
Pulmonary tumor thrombotic microangiopathy was identified in 3.3% (21 of 630) of consecutive autopsy cases with carcinoma, predominantly in patients with adenocarcinoma.
Population
21 patients with pulmonary tumor thrombotic microangiopathy diagnosed from 630 consecutive autopsy cases…
Design
Case_series
Authors
Loading...
PTTM warrants consideration in cancer-associated pulmonary hypertension; leaves open antemortem diagnosis and management strategies.
Observational (n=630)
Pulmonary tumor thrombotic microangiopathy is a rare but important cause of pulmonary hypertension and cor pulmonale in patients with carcinoma, particularly gastric adenocarcinoma.
Herbay et al. (1990) conducted an observational in Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension (n=630). Carcinoma was evaluated on Diagnosis of pulmonary tumor thrombotic microangiopathy. Pulmonary tumor thrombotic microangiopathy was identified in 3.3% (21 of 630) of consecutive autopsy cases with carcinoma, predominantly in patients with adenocarcinoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: